As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

Jim Gaffigan has a sleek new look to match his recent Hollywood renaissance, which includes his hilarious turn on SNL as vice ...

GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...

(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a ...

A new study supports the notion that the same mechanisms that help folks lose weight with Ozempic and its kin also work to ...

People who take popular weight loss drugs like Ozempic can have serious side effects and new research says stopping them can ...

Jim Gaffigan isn't ashamed to admit he jumped on the weight-loss medication bandwagon. In a new interview, the comedian ...

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

New research finds that semaglutide medications like Ozempic and Wegovy may help to lower the risk of alcohol-related issues.

Four out of five men and women in the United States will be overweight or obese by 2050 if current trends hold, a new study ...